Towards New Antifolates Targeting Eukaryotic Opportunistic Infections
Open Access
- 1 April 2009
- journal article
- research article
- Published by American Society for Microbiology in Eukaryotic Cell
- Vol. 8 (4) , 483-486
Abstract
Trimethoprim, an antifolate commonly prescribed in combination with sulfamethoxazole, potently inhibits several prokaryotic species of dihydrofolate reductase (DHFR). However, several eukaryotic pathogenic organisms are resistant to trimethoprim, preventing its effective use as a therapeutic for those infections. We have been building a program to reengineer trimethoprim to more potently and selectively inhibit eukaryotic species of DHFR as a viable strategy for new drug discovery targeting several opportunistic pathogens. We have developed a series of compounds that exhibit potent and selective inhibition of DHFR from the parasitic protozoa Cryptosporidium and Toxoplasma as well as the fungus Candida glabrata . A comparison of the structures of DHFR from the fungal species Candida glabrata and Pneumocystis suggests that the compounds may also potently inhibit Pneumocystis DHFR.Keywords
This publication has 32 references indexed in Scilit:
- Structure-Guided Development of Efficacious Antifungal Agents Targeting Candida glabrata Dihydrofolate ReductaseChemistry & Biology, 2008
- A hundred-year retrospective on cryptosporidiosisTrends in Parasitology, 2008
- Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta‐analysisBritish Journal of Clinical Pharmacology, 2007
- New insights into DHFR interactions: Analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5‐(ω‐carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactionsProteins: Structure, Function, and Bioinformatics, 2006
- Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatusJournal of Clinical Microbiology, 2004
- New 2,4-Diamino-5-(2‘,5‘-substituted benzyl)pyrimidines as Potential Drugs against Opportunistic Infections of AIDS and Other Immune Disorders. Synthesis and Species-Dependent Antifolate ActivityJournal of Medicinal Chemistry, 2004
- 7-Methyl Trimethoprim Analogues as Inhibitors of the Folate Metabolizing EnzymesJournal of Heterocyclic Chemistry, 2003
- Further Studies on 2,4-Diamino-5-(2‘,5‘-disubstituted benzyl)pyrimidines as Potent and Selective Inhibitors of Dihydrofolate Reductases from Three Major Opportunistic Pathogens of AIDSJournal of Medicinal Chemistry, 2003
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D Structural Biology, 1997
- Trimetrexate for the Treatment ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987